PATENT CLAIM ANALYSIS

Application Number: 16266928
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["514", "265100"]

Abstract:
The present invention provides a compound of Formula II, and salts thereof, and a pharmaceutical composition comprising a compound of Formula II: wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and wherein R 3  is hydrogen, an alkyl group having from one to ten carbon atoms, or a halogen. Preferably the compound of Formula II includes wherein R 3  is a halogen, and most preferably wherein the halogen is chlorine. Methods of treating a patient with cancer with these compounds are also provided.

Claim (Index 17):
The pharmaceutical composition of Formula V of  claim 16  wherein X is S and R is H.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 99.0
- Lexical Diversity: 1.96078
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15130219', '13364930', '14859854', '15659155', '15453953']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8206359503865289
- 35 USC 102 Novelty (BERT): 0.5621903416795856
- Combined Prediction Score: 0.7947913895158346
- Mean Citation Score: 387.59098200000005
- Max Citation Score: 544.3622
- Similarity Product: 300.0730981709719

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test